Marex Group’s Alkermes ALKS Stock Holding History

Marex Group’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-19,891	Closed	-$703K	–	1127
2026 Q1	$703K	Sell	19,891 -24,960	-56%	-$774K	﹤0.01%	529
2025 Q4	$1.25M	Buy	44,851 +30,751	+218%	+$921K	0.01%	376
2025 Q3	$423K	Buy	+14,100	New	+$398K	﹤0.01%	542

Other funds holding ALKS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Marex Group's ALKS Position: Q2 2026 in Review

Marex Group sold out of Alkermes (ALKS) in Q2 2026, closing a stake of 19,891 shares — an estimated $703K sold.

Marex Group first reported a position in ALKS in Q3 2025 and held it in 3 quarters. The position peaked at $1.25M in Q4 2025. 425 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

Marex Group reported no remaining Alkermes position as of Q2 2026 after selling out during the quarter.
Marex Group sold 19,891 Alkermes shares in Q2 2026, an estimated $703K.
Marex Group first reported a position in Alkermes in Q3 2025 and held it in 3 quarters.
Marex Group's Alkermes position peaked at $1.25M in Q4 2025.
425 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.